Offer - Urjas Oil for just ₹ 1 X
Olmax M 20 Mg/25 Mg Tablet is a prescription medicine that is available as a Tablet. Olmax M 20 Mg/25 Mg Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Olmax M 20 Mg/25 Mg Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Olmax M 20 Mg/25 Mg Tablet also has some side effects, the most common being Upper respiratory tract infection, Slow heart rate (pulse). Some other side effects of Olmax M 20 Mg/25 Mg Tablet have been listed ahead. Such side effects of Olmax M 20 Mg/25 Mg Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Olmax M 20 Mg/25 Mg Tablet has a Severe effect for pregnant women and Mild effect on lactating mothers. Further, the section on Olmax M 20 Mg/25 Mg Tablet related warnings talks about Olmax M 20 Mg/25 Mg Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Bradycardia (Slow Heart Rate) must refrain from the use of Olmax M 20 Mg/25 Mg Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Olmax M 20 Mg/25 Mg Tablet contraindications section.
Besides this, Olmax M 20 Mg/25 Mg Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Olmax M 20 Mg/25 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Olmax M 20 Mg/25 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmax M 20 Mg/25 Mg Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Olmax M. If you are pregnant, do not take Olmax M without a doctor's advice.
Is the use of Olmax M 20 Mg/25 Mg Tablet safe during breastfeeding?
Olmax M may have very limited harmful effects for breastfeeding women.
What is the effect of Olmax M 20 Mg/25 Mg Tablet on the Kidneys?
Olmax M is not harmful for kidneys.
What is the effect of Olmax M 20 Mg/25 Mg Tablet on the Liver?
Olmax M has very mild side effects on the liver.
What is the effect of Olmax M 20 Mg/25 Mg Tablet on the Heart?
Very few cases of side effects of Olmax M on the heart have been reported.
Olmax M 20 Mg/25 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olmax M 20 Mg/25 Mg Tablet unless your doctor advises you to do so -
Is this Olmax M 20 Mg/25 Mg Tablet habit forming or addictive?
Olmax M 20 Mg/25 Mg Tablet does not cause addiction.
Interaction between Food and Olmax M 20 Mg/25 Mg Tablet
Taking Olmax M 20 Mg/25 Mg Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Olmax M 20 Mg/25 Mg Tablet
Taking alcohol with Olmax M 20 Mg/25 Mg Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850